BEER-SHEVA, Israel, Sept. 23, 2019 /PRNewswire/ -- BGN Technologies, the technology transfer company of Ben-Gurion University (BGU) of the Negev, announced today that it has entered into an exclusive worldwide license agreement with Vaxil Bio (TSX V

ANN ARBOR, Mich., Sept. 23, 2019 /PRNewswire/ -- Michigan's two elite cancer programs are joining forces to find new solutions for prostate cancer. The

SANTA CLARA, Calif., Sept. 23, 2019 /PRNewswire/ -- eHealth, Inc. (NASDAQ: EHTH), a leading private online health insurance exchange, today announced that Scott Flanders, Chief Executive Officer will present at the Cantor 2019 Global Healthcare Conference on Thursday, October 3, 2019 at 1:15 p.m. E.

LITTLE FALLS, N.J., Sept. 23, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2019.

SAN JOSE, Calif., Sept. 23, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today a

WARSAW, Ind., Sept. 23, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter sales and earnings conference call will be broadcast over the Internet on Tuesday, November 5, 2019, at 8:30 a.m. Eastern Time.  A news release detailing the quarterly results will

SHANGHAI, Sept. 23, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical stage biopharmaceutical company exclusively focusing on the discovery and development of potential first-in-class and best-in-class biologics in immuno-oncology and autoimmune diseases, today announced that it has entered into a clinical re

BRENTWOOD, Tenn., Sept. 23, 2019 /PRNewswire/ -- Brookdale Senior Living Inc. today announced it has won a Best Practices award from Health Ethics Trust (the "Trust") for its compliance education program.

INDIANAPOLIS, Sept. 23, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced data from a number of studies across the company's oncology product portfolio will be presented at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, September 27 - October 1, 2019

STAINES-UPON-THAMES, United Kingdom, Sept. 23, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today an